Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxiglutatione. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR known ✓ | P00390 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.73 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.73 |
| ▸ | GLO1 | Q04760 | 4/20 | 0.64 |
| ▸ | NOD1 | Q9Y239 | 5/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.43 |
| ▸ | GRM8 | O00222 | 1/20 | 0.42 |
| ▸ | GRM6 | O15303 | 1/20 | 0.42 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.42 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.42 |
| ▸ | GRM5 | P41594 | 1/20 | 0.42 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.42 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.42 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.42 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.42 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxiglutatione SCHEMBL4362052 | 1.00 | PTGS1 (0.73) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| Oxiglutatione SCHEMBL18744121 | 1.00 | PTGS1 (0.73) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| Oxiglutatione SCHEMBL13561367 | 1.00 | PTGS1 (0.73) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| Oxiglutatione SCHEMBL19579378 | 1.00 | PTGS1 (0.73) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| Oxiglutatione SCHEMBL16377441 | 1.00 | PTGS1 (0.73) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| Oxiglutatione SCHEMBL1533892 | 1.00 | PTGS1 (0.73) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| Oxiglutatione SCHEMBL15475331 | 0.99 | PTGS1 (0.71) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| Oxiglutatione SCHEMBL1230605 | 0.99 | PTGS1 (0.71) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| Oxiglutatione SCHEMBL29386974 | 0.99 | PTGS1 (0.71) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL13930989 | 0.97 | PTGS1 (0.70) | PTGS1GSTK1GLO1NOD1FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8005 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12636312-B2 | Gold clusters (AuCs), composition and method for treatment of liver cirrhosis | WUHAN VAST CONDUCT SCIENCE FOUNDATION CO., LTD. (CN) | 2026-05-26 | — | — | US | claimed |
| US-12636376-B2 | Methods and compositions for use of growth factor antibodies in combination with non-tyrosine targeting kinase inhibitors | IN3BIO LTD. (BM) | 2026-05-26 | — | — | US | claimed |
| US-12624064-B2 | Linker molecule and use thereof in methods for purifying peptides | Gyros Protein Technologies AB (SE) | 2026-05-12 | — | — | US | claimed |
| WO-2026088246-A1 | METHOD FOR PRODUCING LOW-MOLECULAR-WEIGHT COMPOUND | ＮＴＴ株式会社 | 2026-04-30 | — | — | WO | claimed |
| EP-4723516-A1 | OPTICAL TRANSCEIVER | NTT, Inc. (JP) | 2026-04-08 | — | — | EP | claimed |
| US-12560852-B2 | Semiconductor IQ modulator | NTT, INC. (JP) | 2026-02-24 | — | — | US | claimed |
| US-20260048100-A1 | CYTOKINE FUSION PROTEIN CAPABLE OF CONDITIONAL RELEASE AND ACTIVATION, AND PREPARATION AND USE THEREOF | SHANGHAI ZEYIN BIOTECHNOLOGY CO LTD (CN) | 2026-02-19 | — | — | US | claimed |
| EP-4688833-A1 | METHOD OF FORMING MULTI-SPECIFIC ANTIBODIES FROM HOMODIMER ANTIBODIES AND PHARMACEUTICAL PRODUCT INCLUDING MULTI-SPECIFIC ANTIBODIES THUS OBTAINED | Pfizer Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| US-20260034086-A1 | Pet Food Compositions Comprising Caprylic Acid And Docosahexaenoic Acid And/Or Eicosapetaenoic Acid For Use In Treating Struvite Urolithiasis | HILL'S PET NUTRITION, INC. (US) | 2026-02-05 | — | — | US | claimed |
| US-12533378-B2 | Treatment of adverse effects caused by atypical antipsychotics | SHENZHEN PROFOUND VIEW PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2026-01-27 | — | — | US | claimed |
| US-5130418-A | METHOD TO STABILIZE BASIC FIBROBLAST GROWTH FACTOR | CALIFORNIA BIOTECHNOLOGY INC. (US) | 1992-07-14 | — | — | US | claimed |
| EP-0299764-B1 | HAIR TREATMENT PRODUCT | UNILEVER PLC (GB) | 1992-05-27 | — | — | EP | claimed |
| EP-0471793-A4 | IMPROVED FORMS OF BASIC FIBROBLAST GROWTH FACTOR | — | 1992-05-13 | — | — | EP | claimed |
| EP-0471793-A1 | IMPROVED FORMS OF BASIC FIBROBLAST GROWTH FACTOR | CALIFORNIA BIOTECHNOLOGY, INC. (US) | 1992-02-26 | — | — | EP | claimed |
| EP-0448185-A2 | Hair treatment composition | UNILEVER PLC (GB) | 1991-09-25 | — | — | EP | claimed |
| US-5032410-A | Peptides, hepatitis | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1991-07-16 | — | — | US | claimed |
| EP-0399555-A2 | A feed composition for culturing fishes | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1990-11-28 | — | — | EP | claimed |
| WO-1990013310-A1 | IMPROVED FORMS OF BASIC FIBROBLAST GROWTH FACTOR | CALIFORNIA BIOTECHNOLOGY INC. (US) | 1990-11-15 | — | — | WO | claimed |
| US-4812307-A | PERMANENT WAVES | CHESEBROUGH-POND'S INC. (US) | 1989-03-14 | — | — | US | claimed |
| EP-0299764-A2 | Hair treatment product | UNILEVER PLC (GB) | 1989-01-18 | — | — | EP | claimed |